These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11920345)

  • 41. NKF-DOQI guidelines--will they change the treatment of dialysis patients in Germany? National Kidney Foundation. Dialyses Outcomes Quality Initiative.
    Molzahn M
    Kidney Blood Press Res; 1998; 21(2-4):286. PubMed ID: 9762859
    [No Abstract]   [Full Text] [Related]  

  • 42. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup.
    Frankenfield DL; Prowant BF; Flanigan MJ; Frederick PR; Bailie GR; Helgerson SD; Rocco MV
    Kidney Int; 1999 May; 55(5):1998-2010. PubMed ID: 10231465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
    Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
    JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving management of anemia using CQI techniques.
    Berns JS; Cahill C; Okupinski V; O'Neill K
    Nephrol News Issues; 1997 Sep; 11(9):11-3. PubMed ID: 9348865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluoroscopically guided vs modified traditional placement of tunneled hemodialysis catheters: clinical outcomes and cost analysis.
    Yevzlin AS; Song GU; Sanchez RJ; Becker YT
    J Vasc Access; 2007; 8(4):245-51. PubMed ID: 18161669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications.
    Steinberg EP; Eknoyan G; Levin NW; Eschbach JW; Golper TA; Owen WF; Schwab S
    Am J Kidney Dis; 2000 Jul; 36(1):1-11. PubMed ID: 10873866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Facility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Fuller DS; Robinson BM
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):190-199. PubMed ID: 28062678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
    Triolo G; Canavese C; Di Giulio S
    Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].
    Rodríguez CR; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():105-12. PubMed ID: 19018747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endovascular dialysis interventions in the era of DOQI.
    Greenberg JI; Suliman A; Angle N
    Ann Vasc Surg; 2008 Sep; 22(5):657-62. PubMed ID: 18619775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Core Indicators Project.
    McClellan WM; Frankenfield DL; Wish JB; Rocco MV; Johnson CA; Owen WF;
    Am J Kidney Dis; 2001 May; 37(5):E36. PubMed ID: 11325701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How a dedicated vascular access center can promote increased use of fistulas.
    Jackson J; Litchfield TF
    Nephrol Nurs J; 2006; 33(2):189-96. PubMed ID: 16613413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular access for hemodialysis: thrills and thrombosis.
    Gilpin V; Nichols WK
    J Vasc Nurs; 2010 Jun; 28(2):78-83. PubMed ID: 20494299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in anemia at initiation of dialysis in the United States.
    Obrador GT; Roberts T; St Peter WL; Frazier E; Pereira BJ; Collins AJ
    Kidney Int; 2001 Nov; 60(5):1875-84. PubMed ID: 11703606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients.
    Xue JL; Dahl D; Ebben JP; Collins AJ
    Am J Kidney Dis; 2003 Nov; 42(5):1013-9. PubMed ID: 14582045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodialysis vascular access training and practices are key to improved access outcomes.
    Goodkin DA; Pisoni RL; Locatelli F; Port FK; Saran R
    Am J Kidney Dis; 2010 Dec; 56(6):1032-42. PubMed ID: 20961676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adequacy of dialysis and differences in hematocrit among dialysis facilities.
    Ifudu O; Uribarri J; Rajwani I; Vlacich V; Reydel K; Delosreyes G; Friedman EA
    Am J Kidney Dis; 2000 Dec; 36(6):1166-74. PubMed ID: 11096041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The National Kidney Foundation Dialysis Outcomes Quality Initiative.
    Eknoyan G; Levin NW; Steinberg E
    Curr Opin Nephrol Hypertens; 1997 Nov; 6(6):520-3. PubMed ID: 9375263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines.
    Collins AJ; Ebben JP; Gilbertson DT
    Am J Kidney Dis; 2007 Jan; 49(1):135-42. PubMed ID: 17185154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cycler adequacy and prescription data in a national cohort sample: the 1997 core indicators report. Health Care Financing Administration Peritoneal Dialysis Core Indicators Study Group.
    Rocco MV; Flanigan MJ; Prowant B; Frederick P; Frankenfield DL
    Kidney Int; 1999 May; 55(5):2030-9. PubMed ID: 10231468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.